Announced Sat, 10 Oct, 2026 · 12:16 IST

RTA certificate under SEBI Regulation 74(5) filed with BSE

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.5%Reaction day
₹17.51
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.8%+3.7% vs market
Healthcare Service Provider peers, median of 27sector+0.4%+4.1% vs sector

On the reaction day the stock moved 3.7 pts more than Nifty Microcap 250 and 4.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.5+0.8+3.7+0.4+4.1
Next day
+2.7+1.0+1.7-0.5+3.3
2d
+9.1+1.7+7.3+0.2+8.9
3d
+5.8+0.1+5.7-0.9+6.6
4d
+11.2+0.8+10.4-1.4+12.6
5d
+8.8-0.9+9.7-1.9+10.7
1w
+8.5-4.5+13.0-2.8+11.3
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bandaram Pharma Packtech Limited has submitted a compliance certificate from its Registrar and Transfer Agent, Cameo Corporate Services, under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The certificate confirms that securities received from depository participants for dematerialization were processed and listed, and that physical certificates were mutilated and cancelled with the depository name substituted in the register of members within the stipulated time. This is a routine procedural filing made by the Chairman and Managing Director Deepak Reddy Bandaram.

Likely market impact

Routine regulatory compliance filing with no material effect on the company or its shareholders.